Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessas Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist
July 04, 2025 03:00 ET Â | Source: Nxera Pharma Tokyo, Japan and…
HUTCHMED to Announce 2025 Half-Year Financial Results
July 03, 2025 04:30 ET Â | Source: HUTCHMED (China) Limited HONG KONG…
BioVersys and Shionogi Enter Into Global Research Collaboration For Broad-Spectrum Non-Tuberculous Mycobacteria (NTM) Clinical Candidate
July 02, 2025 01:00 ET Â | Source: BioVersys Ad hoc announcement pursuant…
Instil Bio Announces U.S. F.D.A. Clearance of Investigational New Drug (IND) Application for AXN-2510, a PD-L1xVEGF Bispecific Antibody, for a Phase 1 Trial in Relapsed/Refractory Solid Tumors
July 02, 2025 06:00 ET Â | Source: Instil Bio US phase 1…
The Ensign Group Purchases Skilled Nursing Facility in Texas
July 02, 2025 06:00 ET Â | Source: The Ensign Group, Inc. SAN…
The Ensign Group Continues Growth in Idaho
July 02, 2025 06:00 ET Â | Source: The Ensign Group, Inc. SAN…
Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy
July 02, 2025 03:00 ET Â | Source: Belite Bio, Inc -Â 500…
Dr. Anosh Ahmed Advances Chicago Crypto Hub Project Amid National Pro-Crypto Policy Shift
Dr. Anosh Ahmed converts vacant West Side warehouse into blockchain innovation hub,…
The Ensign Group, Inc. Announces Retirement of Its Executive Chairman
June 20, 2025 16:30 ET Â | Source: The Ensign Group, Inc. SAN…
